CENTENNIAL, Colo., April 4, 2018 /PRNewswire-USNewswire/ -- AlloSource and Stryker today announced the launch of ProChondrix®CR, a cryopreserved osteochondral allograft. ProChondrix CR is a single-stage, natural solution for patients in need of articular cartilage repair.
ProChondrix CR is designed to match biomechanical and biochemical properties of normal hyaline
"ProChondrix CR demonstrates our commitment to innovation and our surgeon customers," said Kerr Holbrook, AlloSource Chief Commercial Officer. "This cryopreserved allograft provides opportunities for more surgeons to use ProChondrix CR to help restore patient health. We are proud to work with Stryker on the distribution of this product and look forward to more opportunities to serve surgeons and their patients."
Stryker will distribute ProChondrix CR across multiple treatment areas to help expand access for patients.
About AlloSourceAlloSource is dedicated to advancing the science and use of transplantable allogeneic cells and tissue through pioneering research in regenerative therapies. The organization offers life-saving and life-enhancing solutions in orthopedic, spine, burn and wound procedures to help restore patient health and mobility. As a world leader in cell-based products, fresh cartilage tissue for joint repair and skin allografts to help heal severe burns, AlloSource's products bridge the proven science of allografts with the advanced technology of cells. The company is accredited by the American Association of Tissue Banks and is headquartered in Centennial, CO. For more information, please visit allosource.org.
About StrykerStryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com.
1Data on file at AlloSource
CONTACT: Megan Duggan, 720-382-2766, email@example.com
View original content:http://www.prnewswire.com/news-releases/allosource-and-stryker-launch-prochondrix-cr-cryopreserved-osteochondral-allograft-300624387.html
Subscribe to our Free Newsletters!
Lazy eye or amblyopia occurs when sight in one eye is less than the other in early childhood due to ...
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...View All